Revelation Biosciences (REVB) Institutional Ownership → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free REVB Stock Alerts $2.02 +0.16 (+8.60%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Revelation Biosciences (NASDAQ:REVB)CurrentInstitutional OwnershipPercentage12.80%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$11.26MNumber ofInstitutional Sellers(last 12 months)0 Get REVB Insider Trade Alerts Want to know when executives and insiders are buying or selling Revelation Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data REVB Institutional Buying and Selling by Quarter Ad Crypto 101 Media“Dollar Will Be Worth NOTHING” -MuskElon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.Click here to claim your free seat ticket now. Revelation Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2023 Sabby Management LLC403,233$278K0.2%+14.2%6.401% 7/27/2023Virtu Financial LLC66,972$63K0.0%N/A1.107% 5/19/2023 Anson Funds Management LP213,509$278K0.0%N/A3.700% 5/16/2023 Altium Capital Management LP37,198$48K0.0%N/A0.644% 5/12/2022 Monashee Investment Management LLC817,562$932K0.3%N/A5.420% (Data available from 1/1/2016 forward) REVB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of REVB shares? During the previous two years, the following institutional investors and hedge funds held shares of Revelation Biosciences shares: Sabby Management LLC ($278K), Anson Funds Management LP ($278K), and Virtu Financial LLC ($63K), Altium Capital Management LP ($48K).Learn more on REVB's institutional investors. What percentage of Revelation Biosciences stock is owned by institutional investors? 12.80% of Revelation Biosciences stock is owned by institutional investors. Learn more on REVB's institutional investor holdings. Which institutional investors have been buying Revelation Biosciences stock? The following institutional investors have purchased Revelation Biosciences stock in the last 24 months: Anson Funds Management LP ($213.51K), Virtu Financial LLC ($66.97K), Sabby Management LLC ($50K), and Altium Capital Management LP ($37.20K). How much institutional buying is happening at Revelation Biosciences? Institutional investors have bought a total of 367,679 shares in the last 24 months. This purchase volume represents approximately $12.71M in transactions. Related Companies: GeoVax Labs Institutional Ownership Phio Pharmaceuticals Institutional Ownership Atreca Institutional Ownership Ensysce Biosciences Institutional Ownership Longeveron Institutional Ownership Soligenix Institutional Ownership Exicure Institutional Ownership GT Biopharma Institutional Ownership NovaBay Pharmaceuticals Institutional Ownership Bright Minds Biosciences Institutional Ownership This page (NASDAQ:REVB) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA ‘DeFi Summer’ Projected!Crypto 101 MediaUrgent Nvidia WarningAltimetryBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revelation Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.